We already know that the control of amyloid precursor protein processing is important not only in the course of Alzheimer’s disease (Eggert et al. 2018) but also in diabetes mellitus (Eggert et al. 2021; Catrina and Zheng 2021). Here, APP is linked to Alzheimer disease.